TAG / BIG PHARMA

Despite notoriously denying antidepressant harms—including devastating Post-SSRI Sexual Dysfunction (PSSD)—Anita Clayton is now leading the society that shapes the psychiatric industry’s drug policies.

A landmark reform shuts down deceptive drug ads that fueled overprescribing, misinformation and billions in profits for Big Pharma.

Illinois is the first state to mandate mental health screenings in schools. Opponents call it a reckless experiment that will harm and drug children, while Big Pharma profits.

With millions of Americans prescribed GLP-1 drugs, researchers warn of catastrophic risks ignored by Big Pharma.

Drug regulatory agencies in Germany and Australia have added warnings that atomoxetine can trigger violent or suicidal thoughts—sparking urgent concern over its long‑term use in children and adults.

A 10‑member FDA panel met amid mounting evidence that antidepressants may impair fetal brain development.

Evidence suggests drugmakers manipulated trials and government failed to respond while patients live with permanent loss of sexual function.

The Department of Veterans Affairs partners with Big Pharma to fuel “treatment” that triggers the very suicides it claims to prevent.

Purdue prepares to pay up, leaving unanswered questions about justice, accountability and how hundreds of thousands of lives might have been saved if regulators had acted sooner.

How pharmaceutical reps use charm, freebies and seduction to shape what your doctor prescribes—and why the cozy relationship may be costing you more than you think.